Overview

Axogen is a medical technology company headquartered in Alachua, Florida, founded in 2002 and listed on Nasdaq under the ticker AXGN. It develops and sells implantable products for peripheral nerve repair, including the Avance Nerve Graft and AxoGuard devices. The company serves hospitals, surgery centers, and military hospitals, with customers in medical and related sectors. Its employee count falls in the 500 to 1,000 range.

At a glance

What axogen makes

The company holds ISO 13485 certification and offers products including the AxoGuard Nerve Connector, AxoGuard Nerve Protector, AxoGuard Nerve Cap, and the Avance Nerve Graft.

Products and capabilities described on the company's own site include Connector (source: axogeninc.com).

Certifications

axogen is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — axogeninc.com

Latest developments

• 2026-11-03 — Press Releases :: Axogen, Inc. (AXGN) (axogeninc.com)

• 2026-10-28 — Axogen, Inc. Reports Third Quarter 2026 Financial Results :: Axogen, Inc. (AXGN) (axogeninc.com)

• 2026-10-01 — Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair :: Axogen, Inc. (AXGN) (axogeninc.com)

• 2026-09-10 — Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies :: Axogen, Inc. (AXGN) (axogeninc.com)

• 2026-09-10 — Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock :: Axogen, Inc. (AXGN) (axogeninc.com)

• 2026-02-24 — Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results :: Axogen, Inc. (AXGN) (axogeninc.com)

Company details

Axogen is publicly traded on Nasdaq and reported revenue in the $225.2 million band, serving specialists such as plastic reconstructive, orthopedic, and general surgeons. axogen was founded in 2002, has an estimated 500-1,000 employees, and is headquartered in Alachua, Florida. On the LightSource stability read it is rated "Established & strong": 24 years in operation (founded 2002). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does axogen do?

Axogen is a medical technology company headquartered in Alachua, Florida, founded in 2002 and listed on Nasdaq under the ticker AXGN. It develops and sells implantable products for peripheral nerve repair, including the Avance Nerve Graft and AxoGuard devices. The company serves hospitals, surgery centers, and military hospitals, with customers in medical and related sectors. Its employee count falls in the 500 to 1,000 range.

Where is axogen headquartered?

axogen is headquartered in Alachua, Florida (13631 Progress Boulevard, Alachua, Florida, 32615).

When was axogen founded?

axogen was founded in 2002.

How big is axogen?

axogen has an estimated 500-1,000 employees, with revenue in the 225.2M range.

Is axogen publicly traded?

Publicly traded (NASDAQ: AXGN). Public financial figures are drawn from its filings.

What certifications does axogen hold?

axogen lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• A&K Railroad Materials, Inc.

• A&T Europe Spa

• A.Celli Group

• AAC Clyde Space

• Abiogen Pharma S.P.A.

Last verified Nov 2026. Is this your company? Request a correction.